Journal
MOLECULAR NEUROBIOLOGY
Volume 59, Issue 11, Pages 6684-6700Publisher
SPRINGER
DOI: 10.1007/s12035-022-02990-5
Keywords
Gut microbiota; Trimethylamine N-oxide; Trimethylamine; Neurodegenerative diseases; Cerebral stroke; Sleep disorder
Categories
Funding
- Public Health and Nutrition Division, Department of Biotechnology, Ministry of Science and Technology, Govt of India [BT/PR38038/PFN/20/1528/2020]
Ask authors/readers for more resources
Trimethylamine lyases are enzymes expressed in intestinal microbiota that metabolize dietary nutrients to produce trimethylamine (TMA). Trimethylamine N-oxide (TMAO) is a product of TMA metabolism and has been shown to contribute to the development of metabolic, cardiovascular, and cerebrovascular diseases. This manuscript summarizes the harmful effects of TMAO on neurodegenerative and sleep disorders, as well as its predictive role in neurological disorders. Mechanisms such as activation of inflammatory signaling pathways and mitochondrial dysfunction are involved in TMAO-mediated pathogenesis.
Trimethylamine lyases are expressed in a wide range of intestinal microbiota which metabolize dietary nutrients like choline, betaine, and L-carnitine to form trimethylamine (TMA). Trimethylamine N-oxide (TMAO) is an oxidative product of trimethylamine (TMA) catalyzed by the action of flavin monooxygenases (FMO) in the liver. Higher levels of TMAO in the plasma and cerebrospinal fluid (CSF) have been shown to contribute to the development of risk factors and actively promote the pathogenesis of metabolic, cardiovascular, and cerebrovascular diseases. The investigations on the harmful effects of TMAO in the development and progression of neurodegenerative and sleep disorders are summarized in this manuscript. Clinical investigations on the role of TMAO in predicting risk factors and prognostic factors in patients with neurological disorders are also summarized. It is observed that the mechanisms underlying TMAO-mediated pathogenesis include activation of inflammatory signaling pathways such as nuclear factor kappa B (NF-kappa beta), NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome, and MAPK/JNK in the periphery and brain. Data suggests that TMAO levels increase with age-related cognitive dysfunction and also induce mitochondrial dysfunction, oxidative stress, neuronal senescence, and synaptic damage in the brain. Further research into the relationships between dietary food consumption and gut microbiota-dependent TMAO levels could provide novel therapeutic options for neurological illnesses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available